PCN56 COST-EFFECTIVENESS OF TEMSIROLIMUS FOR METASTIC RENAL-CELL CARCINOMA AND POOR PROGNOSIS PATIENTS IN MEXICO
May 1, 2011, 00:00
10.1016/j.jval.2011.02.911
https://www.valueinhealthjournal.com/article/S1098-3015(11)01050-3/fulltext
Title :
PCN56 COST-EFFECTIVENESS OF TEMSIROLIMUS FOR METASTIC RENAL-CELL CARCINOMA AND POOR PROGNOSIS PATIENTS IN MEXICO
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)01050-3&doi=10.1016/j.jval.2011.02.911
First page :
A164
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
382